Navigation Links
SoluBest Appoints Michael Sheckler, MBA, as CEO
Date:9/10/2008

TEL AVIV, Israel, Sept. 10 /PRNewswire/ -- SoluBest Ltd., a privately held, clinical stage developer of a novel solubilizing technology, has appointed Michael Sheckler, MBA, as CEO. Mr. Sheckler brings over 25 years of pharmaceutical experience to SoluBest.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080910/NEW068LOGO )

Mr. Sheckler began his career with the Ross Division of Abbott Laboratories, selling nutritional and pharmaceutical products. During his time there, he served in a variety of sales roles, winning numerous awards. As a market research analyst, Mr. Sheckler was responsible for the market assessment and product launch plans for several line extensions.

Mr. Sheckler left Ross in 1999 to join Bespak, Inc., a drug delivery technology company, where he held several roles of increasing responsibility. As Head of Marketing for the newly created Nasal Drug Delivery business, he was instrumental in launching the business stream, assessing and growing new business opportunities in the U.S., and developing and implementing the launch and marketing plans for new products.

Upon leaving Bespak, Mr. Sheckler joined Intranasal Technology, Inc, a Kentucky-based nasal drug delivery company as Director of Business Development where he successfully created and implemented a business development and marketing communications strategy positioning the company for its entry into the nasal analgesia market.

Prior to joining SoluBest, Mr. Sheckler served as Vice President of Business Development at Javelin Pharmaceuticals. During his tenure, he realized annual savings of $350M through recognizing and negotiating a new contract manufacturing agreement and strengthened a successful $32M fundraiser through serving an integral role in investor conferences and road shows.

Mr. Sheckler graduated from Indiana University and obtained his MBA from The Fuqu
'/>"/>

SOURCE SoluBest Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
2. Affitech Appoints Dr. Keith McCullagh as Chairman
3. Takeda San Francisco, Inc. Appoints Gregory Landes, Ph.D. Vice President of Antibody Research
4. Algenol Biofuels Appoints Chief Science Officer
5. Axial Biotech appoints new Vice President of Strategic Initiatives
6. Insulet Appoints Bill Arthur as Vice President of Business Development
7. Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
8. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
9. Landauer, Inc. Appoints Two New Members to Board of Directors
10. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
11. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... (PRWEB) August 27, 2014 The Global ... in-depth study on the current state of the Trifluoroacetic ... provides a basic overview of the industry, including definitions, ... Chinese domestic market analysis are provided with a focus ... market. A comparison between the international and Chinese situation ...
(Date:8/27/2014)... 27, 2014  A novel biomarker for rheumatoid ... better identify early-stage disease, when treatment can often ... a new study in The Journal of Rheumatology. ... DGX ) and other institutions found that ... conventional antibody-serum testing, including rheumatoid factor (RF) and ...
(Date:8/27/2014)... Westminster, CO (PRWEB) August 27, 2014 ... image analysis services to the pharmaceutical and medical ... and expansion. The fast growing company has consolidated ... in Aurora and Boulder to Westminster, CO, just north ... and Histology Lab, 7575 W. 103rd Ave., Suite 100, ...
(Date:8/27/2014)... 2014 Tris Pharma, a specialty pharmaceutical company ... that it has been selected as an award winner ... 2014 Awards for Excellence competition in the Business ... of judges from SCORE (Counselors to America,s Small Business) ... honored at a gala event to be held on ...
Breaking Biology Technology:Trifluoroacetic Acid Industry (Asia, Europe, North America, ROW) Analysis Report Now Available at ReportsnReports.com 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4Flagship Biosciences Announces Relocation and Expansion 2Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2
... Pa., Aug. 24 MEDRAD, Inc. has signed a ... to study the impact of automated Fluoro-deoxy-glucose (FDG) administration ... procedures. Clinicians at Moffitt Cancer Center in Tampa, ... measure and infuse patient-specific FDG doses while industrial engineers ...
... , , SAN DIEGO, Aug. ... today announced that Mark Booth has joined the Company as ... of commercial and business development experience to Orexigen. Most ... (TPNA) where he presided over the commercial, medical and scientific ...
... , KVISTGAARD, Denmark, August ... that the US authorities have initiated,negotiations for a ... the,IMVAMUNE(R) smallpox vaccine. This potential new project will ... Advanced Research and,Development Authority) contract for the procurement ...
Cached Biology Technology:MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 2MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 3MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 4Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer 2Bavarian Nordic in Negotiations With the US Authorities for the Further Development of IMVAMUNE(R) 2
(Date:8/27/2014)... getting effective doses of the HIV drug maraviroc, a ... studies, completed before the drug was licensed in 2007, ... is key to removing maraviroc from the body. The ... the protein including nearly half of African-Americans ... to those who lack the protein even when given ...
(Date:8/27/2014)... grass species frequently found in forests has created a ... American toads, a new University of Georgia study has ... the U.S. in the early 1900s, is one of ... more than a dozen states in the past century, ... in forests, it can survive in widely diverse ecosystems ...
(Date:8/27/2014)... what is described by the Volunteer Wildfire Services of ... Cape provincial government warned residents in certain parts of ... veld fires. A high veld fire danger rating ... coast in the Great Kei and Mnquma area. ... thunderstorms. The thunderstorms bring lightning strikes and subsequent ...
Breaking Biology News(10 mins):Dosage of HIV drug may be ineffective for half of African-Americans 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3
... great mysteries of life is how it began. What physical process ... a living cell? For more than a century, scientists have ... life. Until recently, their focus has been trained on how the ... early Earth, or perhaps in space. But because it happened so ...
... firing in a brain reward circuit instantly rendered mice ... a study supported by the National Institutes of Health ... mimic the pattern, previously resilient mice instantly succumbed to ... they avoided other animals and lost their sweet ...
... of Notre Dame biochemist Anthony S. Serianni is providing ... and treating diabetes. Serianni points out that biological ... human body from the natural breakdown of the simple ... in diabetic patients because glucose concentrations in the blood ...
Cached Biology News:ASU researchers propose new way to look at the dawn of life 2ASU researchers propose new way to look at the dawn of life 3Stress-resilience/susceptibility traced to neurons in reward circuit 2Stress-resilience/susceptibility traced to neurons in reward circuit 3Stress-resilience/susceptibility traced to neurons in reward circuit 4Notre Dame research may have important implications for combating diabetes 2
... centrifugal filters are disposable microfiltration devices for the ... the range 100 l to 500 l. They ... 2.2 ml centrifuge tubes. Product Features: ... Low hold up volume ( Fast ...
... The ClearSpin Filter is a novel disposable ... the clarification of bacterial lysates in plasmid ... is a novel, disposable spin filtration device ... bacterial lysates in plasmid purification procedures. The ...
... fixed-angle microcentrifuge rotor at RCF up ... filters consist of a membrane-containing filter ... filter by centrifugation for bacteria removal, ... of cells from media and DNA ...
... C, 0.7 mm depth • Reusable, press-to-seal ... be quickly assembled and disassembled for hybridizing ... of any thickness with up to a ... chambers per slide. Minimize specimen handling, eliminate ...
Biology Products: